conTemporary reflectiOns regarding heart failure manaGEmenT ? How to ovERcome the PorTuguese barriers (TOGETHER-PT); [Reflex?es contempor?neas sobre a gest?o da insufici?ncia card?aca ? Como ultrapassar as barreiras em Portugal]

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • José Carlos De Magalhães Silva Cardoso

    Autor

Participantes de fora da FMUP

  • Santos, J
  • Ara?jo, I
  • Andrade, A
  • Morais Sarmento, P
  • Santos, P.
  • Cardoso, B.
  • Marques, I
  • Peres, M
  • Ferreira, J.
  • Agostinho, J
  • Pimenta, J.

Unidades de investigação

Abstract

Introduction and objectives: Heart failure (HF) is a complex clinical syndrome that is a significant burden in hospitalisations, morbidity, and mortality. Although a significant effort has been made to better understand its consequences and current barriers in its management, there are still several gaps to address. The present work aimed to identify the views of a multidisciplinary group of health care professionals on HF awareness and literacy, diagnosis, treatment and organization of care, identifying current challenges and providing insights into the future. Methods: A steering committee was established, including members of the Heart Failure Study Group of the Portuguese Society of Cardiology (GEIC-SPC), the Heart Failure Study Group of the Portuguese Society of Internal Medicine (NEIC-SPMI) and the Cardiovascular Study Group (GEsDCard) of the Portuguese Association of General and Family Medicine (APMGF). This steering committee produced a 16-statement questionnaire regarding different HF domains that was answered to by a diversified group of 152 cardiologists, internists, general practitioners, and nurses with an interest or dedicated to HF using a five-level Likert scale. Full agreement was defined as ?80% of level 5 (fully agree) responses. Results: Globally, consensus was achieved in all but one of the 16 statements. Full agreement was registered in seven statements, namely 3 of 4 statements for patient education and HF awareness and 2 in 4 statements of both HF diagnosis and healthcare organization, with proportions of fully agree responses ranging from 82.9% to 96.7%. None of the HF treatment statements registered full agreement but 3 of 4 achieved ?80% of level 4 (agree) responses. Conclusion: This document aims to be a call-to-action to improve HF patients? quality of life and prognosis, by promoting a change in HF care in Portugal. ? 2023

Dados da publicação

ISSN/ISSNe:
0870-2551, 2174-2030

Revista Portuguesa de Cardiologia  Sociedade Portuguesa De Cardiologia

Tipo:
Article
Páginas:
225-235
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 1

Citações Recebidas na Scopus: 1

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • Heart failure; Cardiology; Internal medicine; Primary healthcare; Nursing awareness; Diagnosis; Treatment; Healthcare organization; Portugal

Proyectos asociados

Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION) - NCT05465213

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Observacional Comercial (EVOLUTION) . AstraZeneca . 2023

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (ZEUS) - NCT05021835

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Comercial (ZEUS) . Novo Nordisk . 2022

Registo global de insuficiência cardíaca congestiva.

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Observacional Académico (IC_Congestiva) . 2019

This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms (EMPERIAL) - NCT03448406

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Comercial (EMPERIAL) . Boehringer Ingelheim . 2020

Global Congestive Heart Failure

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Observacional Académico (G-CHF) . 2023

Envolva-se com o seu coração: Promoção da adesão terapêutica com um sistema de telemonitorização para pessoas com insuficiência cardíaca crónica. (AdHeart)

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo de Intervenção Académico (AdHeart) . FCT . 2019

Telemedicine: an effective tool for up-titration of prognosis-modifying HFrEF therapy

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico (Telemedicine) . 2023

Sacubitril/Valsartan in everyday clinical practice: the experience of a heart failure clinic

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico (Sacubitril/Valsartan) . 2020

Telemedicine in Heart Failure management

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2022

Can Progress Tests Improve Medical Students’ ECG Interpretation Skills? A Feasibility Trial.

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Académico (ECG) . 2022

Avaliação da aorta ascendente em doentes operados a tetralogia de Fallot: implicações no follow-up clínico e imagiológico

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2020

Hyperkalemia as a limiting factor of Neurohormonal Blockade/Modulation in everyday clinical practice

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2020

Reversão da remodelagem ventricular na miocardiopatia dilatada idiopática

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação